Business development
Strategic business development complements our industry-leading R&D capabilities and is core to our innovation engine and future growth. We seek collaborations across our core areas – oncology/hematology, cardiovascular, neuroscience and immunology – focusing on breakthrough science with potential to deliver first- or best-in-class solutions and addressing unmet medical needs.
 |
19/22 |
 |
>60% |
 |
300+ |
Working together
We have a distinct and decisive approach to partnering that leverages the best of Bristol Myers Squibb and the best of our partners to speed transformational medicines to patients. We strive to be a partner of choice and establish a creative and customized approach for each agreement.
Learn more about our fully dedicated group of experienced leaders that serve as the primary point of contact to foster and strengthen the relationship between Bristol Myers Squibb and partners.
Every day, each of us works to improve outcomes for patients fighting serious diseases. Together, we're building a better future for each other and the patients who need us most.